The RYR-1 Foundation (@RYR1foundation) header
The RYR-1 Foundation (@RYR1foundation) profile picture
Pittsburgh, PA
Joined September 2014
Photo by The RYR-1 Foundation (@RYR1foundation)Photo by The RYR-1 Foundation (@RYR1foundation)Photo by The RYR-1 Foundation (@RYR1foundation)Photo by The RYR-1 Foundation (@RYR1foundation)Photo by The RYR-1 Foundation (@RYR1foundation)Photo by The RYR-1 Foundation (@RYR1foundation)Photo by The RYR-1 Foundation (@RYR1foundation)Photo by The RYR-1 Foundation (@RYR1foundation)Photo by The RYR-1 Foundation (@RYR1foundation)
RyCarma Therapeutics announced that the first patient has been dosed in its Phase 2 clinical trial of surlorian (ARM210), an investigational treatment for RYR1-Related Myopathy (RYR1-RM)! 🔗 Learn more: biospace.com/press-releases/… #strengthinnumbersryr1 #ryr1rd #ryr1 #ryr1community
25
💙 15 DAYS UNTIL GIVINGTUESDAY! 💙 The countdown is on! In just 15 days, our RYR-1-RD community will come together for GivingTuesday on December 1. Help secure the $45,000 match!
24
💙 GivingTuesday is getting closer! On 12/1, we can come together and make a difference for individuals and families living with RYR-1-RD. Your support helps us continue investing in research, patient and family support, education, and advocacy. Help activate the $45,000 match!
1
24
Join advocates from across the country March 2 - 4 in Washington, DC, to share your story and make your voice heard on Capitol Hill! The RARE Foundation is offering travel reimbursements for individuals/caregivers attending. Application Deadline: 11/6/26 bit.ly/4fbVlaz
1
1
44
📰 Our November Newsletter Is Here! As we approach GivingTuesday & the end of the year, we're excited to share that our Board of Directors has pledged $45,000 to MATCH year-end donations! ryr1.org/newsletters/novembe…
2
31
✨ Save the Date: GivingTuesday 2026! The countdown has begun! On 12/1, we’ll come together for GivingTuesday, a global day dedicated to generosity and supporting the causes that matter most. 💙 Together, we can make a difference. Strength In Numbers. 📅 GivingTuesday: 12/1/26
1
22
A new pilot project to develop a research test to clarify VUS in the RYR1 gene. Eligibility: Confirmed diagnosis due to recessive RYR1 variants Symptom onset at birth or during childhood Email: [email protected]
1
1
56
The NIH is enrolling participants in a Natural History Study of RYR-1-Related Disorders (RYR-1-RD) to better understand how these conditions affect individuals over time. 📞 (800) 411-1222 📧 [email protected] 🔎 Reference Study #001737-CC ryr1.org/wp-content/uploads/…
1
30
Clinical Trial Opportunity for RYR1-Related Myopathy A Phase 2 clinical trial is evaluating Surlorian (ARM210, S48168), an investigational therapy for adults with autosomal dominant RYR1-Related Myopathy (RYR1-RM). 👉 Learn more about the study clinicaltrials.gov/study/NCT…
1
30
Missed Our September Webinar? No worries! The recording of “RYR1 Mutations and Statins: What Clinicians and Patients Should Know” is now available on our website! Thank you to Dr. Marks & Dr. Van Petegem for sharing their expertise! Watch here 👉 vimeo.com/1227100479?fl=pl&f…
1
2
71
A new study published in Neuromuscular Disorders examined how RYR1-Related Malignant Hyperthermia (MH) susceptibility and Exertional Rhabdomyolysis (ERM) affect daily life. Read Full Article 👉nmd-journal.com/article/S096…
1
41
📰 Our October Newsletter Is Here! 💙 Stay up to date with the latest from The RYR-1 Foundation! Our October Newsletter is now available and includes exciting news! 📖 Read the October Newsletter: ryr1.org/newsletters/october…
26
The NIH Natural History Study of RYR1-Related Disorders is still enrolling participants! This study helps researchers better understand how RYR-1-RD affects individuals over time and can help improve care and support the development of future treatments. bit.ly/4fAMX5r
1
39
🧬 Hope Through Research: Advancing Potential RYR1 Treatments. A renewed NIH grant led by Dr. Dirksen & Dr. Dowling is advancing innovative approaches to RYR1-related myopathy, including research by Dr. Tasfaout! 👉bit.ly/4i80zqg
1
54